[Federal Register Volume 76, Number 159 (Wednesday, August 17, 2011)]
[Notices]
[Pages 51036-51037]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-20919]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-11-0802]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-5960 
and send comments to Daniel Holcomb, CDC Reports Clearance Officer, 
1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail to 
<a href="/cdn-cgi/l/email-protection#caa5a7a88aa9aea9e4ada5bc"><span class="__cf_email__" data-cfemail="7a1517183a191e19541d150c">[email protected]</span></a>.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Active Bacterial Core Surveillance (ABCs) Projects--OMB 0920-0802, 
Expiration January 31, 2012 (Revision)--National Center for 
Immunization and Respiratory Disease (NCIRD), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    CDC is requesting a revision to the approved data collection 
instruments for Active Bacterial Core surveillance (ABCs), to add 
supplemental questions for invasive methicillin-resistant 
Staphylococcus aureus (MRSA). CDC requests OMB approval to collect 
supplemental information to assess risk factors for invasive MRSA among 
patients recently discharged from acute care hospitals. Seventeen acute 
care facilities in 7 ABCs/EIP sites (CA, CT, CO, GA, NY, MN, TN) will 
participate in the collection of supplemental information for ABCs 
MRSA.
    Preventing healthcare-associated invasive MRSA infections is one of 
CDC's priorities. Essential steps in reducing the occurrence of 
healthcare-associated invasive MRSA infections are to quantify the 
burden and to identify modifiable risk factors associated with invasive 
MRSA disease. The current ABCs MRSA surveillance has been essential to 
quantify the burden of invasive MRSA in the United States. Through this 
surveillance CDC was able to estimate that 94,360 invasive MRSA 
infections associated with 18,650 deaths occurred in the United States 
in 2005. The majority of these infections (58%) had onset in the 
community or within 3 days of hospital admission and occurred among 
individuals with recent healthcare exposures (healthcare-associated 
community-onset [HACO]). More recent data from the CDC's EIP/ABCs 
system have shown that two thirds of invasive HACO MRSA infections 
occur among persons who are discharged from an acute care hospital in 
the prior 3 months. Risk factors for invasive MRSA infections post-
discharge have not been well evaluated, and effective prevention 
measures in this population remain uncertain.
    The goal of the supplemental questions to be added to ABCs MRSA 
surveillance is to assess risk factors for invasive healthcare-
associated MRSA infections, which will inform the development of 
targeted prevention measures. This activity supports the HHS Action 
Plan for elimination of healthcare-associated infections. This change 
will result in minimal impact on the current public burden.

[[Page 51037]]

    An estimated total of 450 new patients (150 patients with HACO MRSA 
infection and 300 patients without HACO MRSA infection) will be 
contacted for the MRSA interview annually. This estimate is based on 
the numbers of MRSA cases reported by the EIP sites annually (http://www.cdc.gov/abcs/reports-findings/survreports/mrsa08.html) who are 18 
years of age or older, had onset of the MRSA infection in the community 
or within 3 days of hospital admission, and history of hospitalization 
in the prior 3 months. There are no costs to respondents other than 
their time. The total response burden for the study is estimated as 
follows:
    The OMB-approved ABCs MRSA form (<greek-i>0920-0802) will be used 
to identify patients to be contacted for a telephone interview. These 
450 patients will be screened for eligibility and those considered to 
be eligible will complete the telephone interview. We anticipate that 
350 of the 450 patients screened will complete the telephone interview 
across all 7 EIP sites per year. We anticipate the screening questions 
to take about 5 minutes and the telephone interview 20 minutes per 
respondent.

                                             Table--Estimated Burden
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of       Number of      burden per     Total burden
     Type of  respondents           Form name       respondents    responses per    respondent      (in hours)
                                                                    respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Hospital Patients.............  Screening Form..             450               1            5/60              38
                                Telephone                    350               1           20/60             117
                                 interview.
----------------------------------------------------------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............             155
----------------------------------------------------------------------------------------------------------------


    Dated: August 10, 2011.
Daniel Holcomb,
Reports Clearance Officer, Centers for Disease Control and Prevention.
[FR Doc. 2011-20919 Filed 8-16-11; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>